Medicine and Dentistry
Pediatrics
100%
Chronic Kidney Disease
64%
Nephrotic Syndrome
39%
Diseases
38%
Pediatrics Patient
36%
Cohort Analysis
28%
End Stage Renal Disease
25%
Focal Segmental Glomerulosclerosis
22%
Prevalence
22%
Proteinuria
21%
Acute Kidney Injury
19%
Atypical Hemolytic Uremic Syndrome
18%
Congenital Nephrotic Syndrome
18%
Moyamoya Disease
18%
Renovascular Hypertension
18%
Quality of Life
14%
Nephropathy
14%
Pediatric Quality of Life Inventory
14%
Kidney Graft
14%
Pediatric Nephrology
13%
Continuous Renal Replacement Therapy
12%
Nephrocalcinosis
12%
Neonate
12%
Rhabdomyolysis
12%
BK Virus
12%
Immunoglobulin A Nephropathy
11%
Clinical Guideline
10%
Glomerular Filtration Rate
9%
Kidney Transplantation
9%
Posterior Reversible Encephalopathy Syndrome
9%
Thrombotic Thrombocytopenic Purpura
8%
Glomerulosclerosis
7%
Podocyte
7%
Infection
7%
Influenza Vaccine
7%
Virus Infection
7%
Kidney Function
6%
Albumin
6%
Adverse Event
6%
Left Ventricular Hypertrophy
6%
Anemia
6%
Short Stature
6%
Steroid Treatment
6%
Body Mass Index
6%
Cardiovascular Disease
6%
Lupus Nephritis
6%
QT Prolongation
6%
Fifth Disease
6%
Bone Disease
6%
2009 H1N1 Influenza
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
36%
Renovascular Hypertension
18%
Cohort Study
15%
Replacement Therapy
14%
Acute Kidney Failure
13%
2009 H1N1 Influenza
13%
Prevalence
12%
Adverse Event
12%
End Stage Renal Disease
12%
Measles
12%
Cardiovascular Disease
11%
Diseases
11%
Live Attenuated Influenza Vaccine
9%
Influenza A (H1N1)
8%
Trough Level
8%
Heart Left Ventricle Hypertrophy
7%
Hemodialysis
7%
Dyslipidemia
7%
Syndrome
7%
Pandemic Influenza
7%
Disease Exacerbation
6%
Uric Acid
6%
Nephrotic Syndrome
6%
Erythema Infectiosum
6%
QT Prolongation
6%
Heart Ventricle Fibrillation
6%
Hypervolemia
6%
Moyamoya Disease
6%
Left Ventricular Diastolic Dysfunction
6%
Puromycin Aminonucleoside
6%
Nephrotoxicity
6%
Vancomycin
6%
Disease Duration
6%
Elimination
6%
Seroprevalence
6%
Albumin
6%
Congenital Rubella Syndrome
6%
Diastolic Dysfunction
6%
Hyperammonemia
6%
Rhabdomyolysis
6%
Poliomyelitis Virus
6%
Teicoplanin
6%
Bartter Syndrome
6%
Fosfomycin
6%
Nitrofurantoin
6%
Extended Spectrum Beta Lactamase
6%
Escherichia Coli Pneumonia
6%
Klebsiella pneumoniae
6%
Cardiovascular Risk
6%
